LISA WIRTH: Open Payments
NPI 1932171758 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,511 in 101 payments from 15 companies in 2025. Trend: 2023 $1,431 · 2024 $733 · 2025 $1,511
Food & beverage: $1,440Education: $71
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 36 | $530 |
| Alkermes, Inc. | 10 | $188 |
| Vanda Pharmaceuticals Inc. | 17 | $169 |
| Neurocrine BioSciences, Inc. | 12 | $159 |
| Teva Pharmaceuticals USA, Inc. | 4 | $104 |
| Otsuka America Pharmaceutical, Inc. | 4 | $67 |
| Tris Pharma Inc | 3 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $48 |
| Corium, LLC | 5 | $38 |
| ABBVIE INC. | 2 | $36 |
Products named: CAPLYTA, LYBALVI, INGREZZA, HETLIOZ, FANAPT, REXULTI, Dyanavel XR, TRINTELLIX.
Industry payments across GA — which companies pay providers there.
